drugset / Trial / NCT00846118

Differential Intervention Trial by Standard Therapy Versus Pitavastatin in Patients With Chronic Hemodialysis (DIALYSIS)

NCT00846118

Terminated 905 enrolled Chieko Hamada
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to verify whether pitavastatin prevents from cardiovascular events and improves the mortality in chronic hemodialysis patients with hypercholesteremia.

Timeline

Start
2009-02-01
Primary completion
2011-01-31
Completion
2014-09-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pitavastatin Small molecule 1 mg
Comparator Pitavastatin Small molecule 4 mg